| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42571-221-05 | 42571-221 | HUMAN PRESCRIPTION DRUG | RASAGILINE | Rasagiline | TABLET | ORAL | 20190403 | N/A | ANDA | ANDA207004 | Micro Labs Limited | RASAGILINE MESYLATE | 1 mg/1 | 500 TABLET in 1 BOTTLE (42571-221-05) |
| 42571-221-10 | 42571-221 | HUMAN PRESCRIPTION DRUG | RASAGILINE | Rasagiline | TABLET | ORAL | 20190403 | N/A | ANDA | ANDA207004 | Micro Labs Limited | RASAGILINE MESYLATE | 1 mg/1 | 1000 TABLET in 1 BOTTLE (42571-221-10) |
| 42571-221-30 | 42571-221 | HUMAN PRESCRIPTION DRUG | RASAGILINE | Rasagiline | TABLET | ORAL | 20190403 | N/A | ANDA | ANDA207004 | Micro Labs Limited | RASAGILINE MESYLATE | 1 mg/1 | 30 TABLET in 1 BOTTLE (42571-221-30) |
| 42571-220-30 | 42571-220 | HUMAN PRESCRIPTION DRUG | RASAGILINE | Rasagiline | TABLET | ORAL | 20190403 | N/A | ANDA | ANDA207004 | Micro Labs Limited | RASAGILINE MESYLATE | .5 mg/1 | 30 TABLET in 1 BOTTLE (42571-220-30) |
| 42571-220-10 | 42571-220 | HUMAN PRESCRIPTION DRUG | RASAGILINE | Rasagiline | TABLET | ORAL | 20190403 | N/A | ANDA | ANDA207004 | Micro Labs Limited | RASAGILINE MESYLATE | .5 mg/1 | 1000 TABLET in 1 BOTTLE (42571-220-10) |
| 42571-220-05 | 42571-220 | HUMAN PRESCRIPTION DRUG | RASAGILINE | Rasagiline | TABLET | ORAL | 20190403 | N/A | ANDA | ANDA207004 | Micro Labs Limited | RASAGILINE MESYLATE | .5 mg/1 | 500 TABLET in 1 BOTTLE (42571-220-05) |